Bioactive Glass Preloaded with Antibiotics for Delivery of Long-Term Localized Drug Release Exhibiting Inherent Antimicrobial Activity
Source abstract
Abstract
Bacterial infections caused by biofilms are often difficult to treat due to the resistant nature of the latter, which require high concentrations of antibiotics to be applied for prolonged periods to achieve complete eradication. This study aimed to design a new drug delivery system for long-term drug release for the treatment of bacterial infections. Specifically, bioactive glass preloaded with vancomycin (BG-V) and synthesized without any thermal treatment was designed to load higher percentages of the drug and release it slowly over time. In this study, BG-V was-synthesized using a solution containing vancomycin, with glass being formed around it by adding metal precursors to this solution. The BG-V was then left to dry at room temperature to form a white powder with vancomycin trapped in the structure. The successful synthesis of BG-V was confirmed by X-ray diffraction, Fourier-transform infrared spectroscopy, scanning emission microscopy, and nitrogen adsorption–desorption analysis. The results showed that BG-V was successfully developed using FTIR, showing vancomycin within the BG-V structure. After the drug release, BG-V showed great bioactivity, as indicated by the XRD and bacterial studies. The result shows that drug release is controlled by a combination of diffusion through the matrix and the gradual erosion of the delivery system.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Facial Trauma and Fracture Management · Medical and Biological Ozone Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Electrical, Computer & Biomedical Engineering, Toronto Metropolitan University, Toronto, ON M5B 2K3, Canada
Department of Chemical Engineering, Toronto Metropolitan University, Toronto, ON M5B 2K3, Canada
References (43)
Show source-provided references
1. The story of Bioglass10.1007/s10856-006-0432-z ↗
2. An investigation of bioactive glass powders by sol-gel processing10.1002/jab.770020403 ↗
3. Glass and bioglass nanopowders by flame synthesis10.1039/b517501a ↗
4. Review of bioactive glass: From Hench to hybrids10.1016/j.actbio.2012.08.023 ↗
5. In vitro bioactivity evaluation of α-calcium sulphate hemihydrate and bioactive glass composites for their potential use in bone regeneration10.1007/s12034-018-1558-6 ↗
6. Na2CaSi2O6–P2O5 Based Bioactive Glasses. Part 1: Elasticity and Structure10.1016/j.jnoncrysol.2005.08.020 ↗
7. Characterization of melt-derived 45S5 and sol-gel-derived 58S bioactive glasses10.1002/jbm.10026 ↗
8. Vallet-Regi, M., and Acros, D. (2020). Bioactive Glasses: Properties, Composition and Recent Applications, Nova Science.
9. Synthesis of ternary bioactive glass derived aerogel and xerogel: Study of their structure and bioactivity10.2478/nbec-2018-0016 ↗
10. Araújo, M., Miola, M., Baldi, G., González, J., and Verné, E. (2016). Bioactive glasses with low ca/p ratio and enhanced bioactivity. Materials, 9.10.3390/ma9040226 ↗
11. Mukundan, L.M., Nirmal, R., Vaikkath, D., and Nair, D. (2013). A new synthesis route to high surface area sol gel bioactive glass through alcohol washing. Biomatter, 3.10.4161/biom.24288 ↗
12. Biomineralization behavior of ternary mesoporous bioactive glasses stabilized through ethanol extraction process10.1016/j.jnoncrysol.2022.121630 ↗
13. Almasri, D., and Dahman, Y. (2023). Prosthetic Joint Infections: Biofilm Formation, Management, and the Potential of Mesoporous Bioactive Glass as a New Treatment Option. Pharmaceutics, 15.10.3390/pharmaceutics15051401 ↗
14. Insights into key interactions between vancomycin and bacterial cell wall structures10.1021/acsomega.7b01483 ↗
15. Vancomycin displays time-dependent eradication of mature staphylococcus aureus biofilms10.1002/jor.23291 ↗
16. Development of antibiotic loaded mesoporous bioactive glass and its drug release kinetics10.1016/j.ceramint.2019.10.264 ↗
17. Well-ordered mesoporous bioactive glasses (MBG): A promising bioactive drug delivery system10.1016/j.jconrel.2005.11.002 ↗
18. Crystal structure of Vancomycin10.1016/S0969-2126(96)00156-6 ↗
19. Recent advances and future perspectives of sol–gel derived porous bioactive glasses: A review10.1039/D0RA04287K ↗
20. Bruschi, M.L. (2015). Modify the Drug Release from Pharmaceutical Systems, Woodhead Publishing.
21. Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles10.1016/j.ejpb.2015.02.017 ↗
22. Kinetic modeling on drug release from controlled drug delivery systems
23. 2005 BSAC standardized disc susceptibility testing method (version4)10.1093/jac/dki124 ↗
24. Ag nanoparticles and vancomycin comodified layered double hydroxides for simultaneous capture and disinfection of bacteria10.1039/c3tb20871k ↗
25. Auniq, R., Boonyang, U., and Hirun, N. (2020). Three-Dimensionally Ordered Macroporous-Mesoporous Bioactive Glass Ceramics for Drug Delivery Capacity and Evaluation of Drug Release. Ceramic Materials, IntechOpen.
26. Silk coating on poly(ε-caprolactone) microspheres for the delayed release of vancomycin10.3109/02652048.2010.534824 ↗
27. Memar, M.Y.Y., Mina, Y., Farajnia, S., and Moghaddam, F. (2023). Antibacterial and biofilm-inhibitory effects of vancomycin-loaded mesoporous silica nanoparticles on methicillin-resistant staphylococcus aureus and gram-negative bacteria. Arch. Microbiol., 205.10.1007/s00203-023-03447-6 ↗
28. Synergistic effect of vancomycin and gallic acid loaded MCM-41 mesoporous silica nanoparticles for septic arthritis management10.1016/j.jddst.2023.104353 ↗
29. Mesoporous Bioactive Glass Composition Effects on Degradation and Bioactivity
30. Tabassum, S., Saqib, M., Batool, M., Sharif, F., Gilani, M.A., and Huck, O. (2024). Eco-friendly synthesis of mesoporous bioactive glass ceramics and functionalization for drug delivery and hard tissue engineering applications. Biomed. Mater., 19.10.1088/1748-605X/ad2c19 ↗
31. Bioactive glass 58S prepared using an innovation sol-gel process10.2298/PAC1901098B ↗
32. Anh Tuan, T., Guseva, E.V., Anh, N., and Dat, H.T. (2021). Simple and Acid-Free Hydrothermal Synthesis of Bioactive Glass 58SiO2-33CaO-9P2O5 (wt%). Crystals, 11.10.3390/cryst11030283 ↗
33. Systematic analysis of the nitrogen adsorption-desorption isotherms recorded for a series of microporous—Mesoporous amorphous aluminosilicates using classical methods10.1021/acs.jced.3c00257 ↗
34. Bio-inspired synthesis of microporous bioactive glass-ceramic using CT-DNA as a template10.1039/c3tb21212b ↗
35. Sol-gel processing of bioactive glass nanoparticles: A review10.1016/j.cis.2017.03.008 ↗
36. Physical Characteristic and In-Vitro Bioactivity Property of Sintered Glasses made via Sol-Gel and Powder Sintering Process
37. Bioactive Glass 45S5 from Diatom Biosilica10.1016/j.jsamd.2017.09.002 ↗
38. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
39. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)10.1016/S0169-409X(01)00112-0 ↗
40. Mathematical models in drug delivery: How modeling has shaped the way we design new drug delivery systems10.1016/j.jconrel.2014.06.041 ↗
41. Aminzadeh, Z., Yadegarynia, D., Fatemi, A., Dehkordi, E.T., and Armaki, S.A. (2014). Vancomycin Minimum Inhibitory Concentration for Methicillin-Resistant Staphylococcus aureus Infections; Is There Difference in Mortality Between Patients?. Jundishapur J. Microbiol., 7.10.5812/jjm.12831 ↗
42. Influence of Vancomycin Infusion Methods on Endothelial Cell Toxicity10.1128/AAC.03694-14 ↗
43. Enhanced antimicrobial properties of bioactive glass using strontium and silver oxide nanocomposites10.1080/21870764.2018.1564477 ↗